Parsabiv Could Allow Amgen To Maintain Control Of Calcimimetics Market

 
• By Michael Cipriano
Lion
Amgen looks set to retain market dominance with Parsabiv • Source: Shutterstock

More from Drug Pricing

More from Scrip